Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | ISM6331 |
Synonyms | |
Therapy Description |
ISM6331 is a pan-TEAD inhibitor, which potentially decreases Tead transcriptional activity leading to decreased tumor cell growth (Cancer Res (2024) 84 (6_Supplement): 1656). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
ISM6331 | ISM-6331|ISM 6331 | ISM6331 is a pan-TEAD inhibitor, which potentially decreases Tead transcriptional activity leading to decreased tumor cell growth (Cancer Res (2024) 84 (6_Supplement): 1656). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT06566079 | Phase I | ISM6331 | Study of ISM6331 in Participants With Advanced/Metastatic Malignant Mesothelioma or Other Solid Tumors | Recruiting | USA | 1 |